Evidence map›Paper›PMID 16480768›Full record

ArticleDevelopmental and comparative immunology2006

Evolution of antibody class switching: identification and transcriptional control of an Inu exon in the duck (Anas platyrhynchos).

Mats L Lundqvist, Bryan R McElveen, Darlene L Middleton, Robert Chapman, Gregory W Warr

Open access · greenAbstract read
In one paragraph

Article in Developmental and comparative immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mats L LundqvistMarine Biomedicine and Environmental Sciences Center and Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 331 Fort Johnson Road, Charleston, SC 29412, USA. lundquml@musc.edu
Bryan R McElveen
Darlene L Middleton
Robert Chapman
Gregory W Warr
Medical University of South Carolina · USSouth Carolina Department of Natural Resources · US

Funding

DUCK ANTIBODY GENES--UNUSUAL ORGANIZATION AND EXPRESSIONR01AI045111 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WARR, GREGORY W · 1999 to 2007
$1.3M
NIAID NIH HHS R01 AI045111NIAID NIH HHS R01 AI045111-07NIAID NIH HHS R01AI45111
6 · The paper itself

Abstract

Immunoglobulin class switching is characteristic to the tetrapod lineage, but the nature of this process has been elucidated only in mammals, where I-exon transcription initiates and directs the recombination in the IgH locus. Here, it is shown that an I-exon occurs 5' of the nu (IgY constant region) gene of the duck (Anas platyrhynchos): it is longer than mammalian I-exons and comprised primarily of tandem repeats. The Inu promoter was identified and shown to be responsive to stimulation with IL-4 but not LPS. It contains Oct, LYF-1, ATF, and C/EBP motifs. Site directed mutagenesis indicates that 2 C/EBP motifs are uniquely necessary for the response of the promoter to IL-4, as tested in the mouse pre-B cell line, 70Z/3. These results support the conclusion that the signal transduction pathways controlling I-exon promoter responses to cytokines have been highly conserved in vertebrate evolution.

Indexed as

Transcription, GeneticAmino Acid SequenceAnimalsCytokinesDucksExonsGene LibraryGenes, ImmunoglobulinImmunoglobulin Class SwitchingImmunoglobulin Constant RegionsImmunoglobulinsMiceMolecular Sequence DataMutagenesis, Site-DirectedPromoter Regions, GeneticReverse Transcriptase Polymerase Chain ReactionCytokinesIgYImmunoglobulin Constant RegionsImmunoglobulins

Identifiers

PMID16480768
PMCPMC1400595
OpenAlexW2035851675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.